Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05522881 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Registry Study of Genetic Alterations of Oropharyngeal Cancer in Taiwan

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv10
  2. Primary and study completion dates: Dec 30, 2029 to Dec 2029
    • Collaborators: 6 to 7
    v9
  3. Enrollment target: 300 to 410v8
  4. Eligibility criteria expanded, about 43 words
    • Site contacts updated at 2 of 7 sites
    • Study arms: 4 to 6
    v7
  5. Study sites: 6 to 7v6
Show 4 earlier versionsHide 4 earlier versions
  1. Start date changed from estimate of Dec 25, 2022 to Nov 25, 2022v5
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Oct 25, 2022 to Dec 25, 2022
    • Study sites: 0 to 6
    v4
  3. Re-verified, no change to tracked fieldsv3
  4. Eligibility criteria shortened, about 1 wordv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
We will use the next-generation sequencing (NGS) technology to identify genomic alterations of Taiwanese HPV positive and negative oropharyngeal squamous cell carcinoma (OPSCC) for novel biomarker development and the study design of potential clinical trials or translational research.
Trial Details
NCT Number NCT05522881
Lead Sponsor National Health Research Institutes, Taiwan
Collaborators: National Taiwan University Hospital, Taipei Veterans General Hospital, Taiwan, China Medical University Hospital, Taichung Veterans General Hospital, National Cheng-Kung University Hospital, Kaohsiung Veterans General Hospital., Kaohsiung Medical University Chung-Ho Memorial Hospital
Conditions
(from sponsor)		 Oropharyngeal Squamous Cell Carcinoma
Related terms Squamous Cell Carcinoma of Head and Neck
Enrollment 410 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov